Efficacy and Safety of Tocilizumab in Adult's Still Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
Patients with adult\'s Still disease suffer from acute inflammatory symptoms such as fever, arthritis, rash, and acute phase response often requiring high dose corticosteroids. In view of several case reports which have shown dramatic improvement in patients treated with Tocilizumab and a phase 2 study of this drug in children with Still\'s disease, the objective of the current study is to assess the efficacy and safety of Tocilizumab in patients with adult\'s Still disease.
Epistemonikos ID: 059849c5bf27106f768eb4387d9ab71f4ec11212
First added on: May 05, 2024